Summary
Most previous studies have not significantly correlated urinary kallikrein to urinary kinins. We investigated whether urinary kininogen might influence kinin formation within the urine. On an ad-lib diet the 24 hour excretion of total and intact kininogen, kinins and kallikrein was determined in 24 control subjects, 20 untreated essential hypertensives, 12 vith end-stage renal disease and 8 subjects with liver disease. Kallikrein and kinins were measured by a direct radioimmunoassay. Total kininogen was determined from the sum of preformed kinins and kinins generated after trypsin (intact kininogen), Cross reactivity between purified human low molecular weight kininogen and bradykinin antiserum was 3%. Total and intact kininogen were significantly correlated with kinins in controls, essential hypertension and liver disease. In essential hypertension, end-stage renal and liver diseases kinins were significantly decreased. This was associated with a reduction in kininogen but not kallikrein in essential hypertension and liver disease, and a reduction in kallikrein but not kininogen in end-stage renal disease. Thus, renal kinin generation in various states may be affected by either or both kininogen and kallikrein.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
N. G. Levinsky, The renal kallikrein-kinin system, Circ. Res., 44: 441–451, (1979).
O. A. Carretero and A. G. Scicli, The renal kallikrein-kinin system, Am. J. Physiol., 238: F247–255, (1980).
W. Lieberthal, N. B. Oza, D. B. Bernard, and N. G. Levinsky, The effect of cations on the activity of human urinary kallikrein, J. Biol. Chem., 257: 10827–10830, (1982).
J. J. Pisano, J. Corthorn, K. Yates, and J. V. Pierce: The kallikrein-kinin system in the kidney, Controv. Nephrol., 12: 116–125, (1978).
J. L. Hulthen, J. F. Dymling, and B. Hokfeit, Kinins in relation to kallikrein activity, kininogen, electrolytes, aldosterone and catecholamines in urine from normal individuals, Acta. Physiol. Scand., 110: 307–314, (1980).
D. Proud, M. Perkins, J. V. Pierce, K. N. Yates, P. F. Highet, P. L. Herring, M. Mangkornkanok/Mark, R. Bahu, F. Carone, and J. J. Pisano, Characterization and localization of human renal kininogen, J. Biol. Chem., 256: 10634–10639, (1981).
M. S. Weinberg, C. A. St. Martin, P. Azar, M. Taylor, W. M. Trebbin, and R. J. Solomon, Urokininogen: A possible regulator of the kallikrein-kinin system, Clin. Res., 32: 459A, (1984).
W. Muller-Esterl, I. Juso, and H. Fritz, Quantitation and differentiation of human kininogens by enzyme-linked immunosorbent assays (ELISA), Fresenius Z. Anal. Chem., 317: 733–734, (1984).
V. Hial, H. R. Keiser, and J. J. Pisano, Origin and content of methionyl-lysyl-bradykinin, lysyl-bradykinin and bradykinin in human urine, Biochem. Pharmacol., 25: 2499–2503, (1976).
M. S. Weinberg, N. B. Oza, and N. G. Levinsky, Components of the kallikrein-kinin system in rat urine, Biochem. Pharmacol., 33: 1779–1782, (1984).
N. B. Oza, W. Lieberthal, D. B. Bernard, and N. G. Levinsky, Anti body that recognizes total human urinary kallikrein, Radioimmunological determination of inactive kallikrein, J. Immunol., 126: 2361–2364, (1983).
W. Lieberthal, L. Arbeit, N. B. Oza, D. B. Bernard, and N. G. Levinsky, Reduced ratio of active-to-total urinary kallikrein in essential hypertension, Hypertension, 5: 603–609, (1983).
B. E. Huitema, The analysis of covariance and alternatives, John Wiley & Sons, New York, NY, pp. 238–240.
F. N. Kerlinger and E. J. Pedhazer, Multiple regression in behavioral research, Holt, Rinehart & Winston, Inc., New York, NY, pp. 83.
W, Muller-Esterl, M. Vohle-Timmermann, B. Boos, and B. Dittman, Purification and properties of human low molecular weight kininogen, Biochim. Biophys. Acta., 706: 145–152, (1982).
M. Maier, K. F. Austen, and J. Spragg, Kinetic analysis of the interaction of human issue kallikrein with single chain human high and low molecular weight kininogens, Proc. Natl. Acad. Sci., 80: 3928–3932, (1983).
J. V. Pierce and J. A. Guimaraes, Further characterization of highly purified human plasma kininogens, in: The Chemistry and Biology of the kallikrein-Kinin System in Health and Disease by J. J. Pisano and K. F. Austen, eds., U. S. Government Printing Office, Washington, D. C., pp. 121–128, (1977).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1986 Plenum Press, New York
About this chapter
Cite this chapter
Weinberg, M.S., Trebbin, W.M., Solomon, R.J. (1986). Urinary Kininogen: A Possible Regulator of Kinin Formation in Normal Individuals and Subjects with Essential Hypertension, End-Stage Renal and Liver Disease. In: Greenbaum, L.M., Margolius, H.S. (eds) Kinins IV. Advances in Experimental Medicine and Biology, vol 198A. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5143-6_17
Download citation
DOI: https://doi.org/10.1007/978-1-4684-5143-6_17
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-5145-0
Online ISBN: 978-1-4684-5143-6
eBook Packages: Springer Book Archive